Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery

NCT ID: NCT05583916

Last Updated: 2022-10-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-07

Study Completion Date

2023-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Phase I to evaluate the safety and feasibility of same-day discharge in selected participants undergoing minimally-invasive lung surgery and who receive an enhanced recovery pathway.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lung Cancer Patients

Patients with stage I or II primary lung cancer or pulmonary metastasis scheduled to undergo surgery.

Group Type OTHER

Same Day Discharge - Video-Assisted Thoracoscopic Surgery (VATS) Lung

Intervention Type PROCEDURE

All patients will be scheduled to surgery at the start of the day and will be discharged within the same day as the procedure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Same Day Discharge - Video-Assisted Thoracoscopic Surgery (VATS) Lung

All patients will be scheduled to surgery at the start of the day and will be discharged within the same day as the procedure.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed or verbal informed consent by participant
* Male and female adults, age 18 and above
* Clinical stage I-II lung cancer (suspected, proven, unproven), or secondary pulmonary malignancy
* BMI \< 35
* ECOG 0-1
* Eligible for surgery and lung cancer resection (FEV1 \> 60%, DLCO \> 60%)
* Elective VATS anatomic resection (segmentectomy or lobectomy), or wedge resection
* Capable caregiver for discharge home

Exclusion Criteria

* Clinical stage III lung cancer
* Surgery requiring pneumonectomy
* Neoadjuvant therapy
* Active pregnancy or breastfeeding
* History of chronic pain syndromes
* History of chronic opioid use
* Concomitant major surgery indicated with current admission to hospital
* Anticipated intraoperative complication including conversion to thoracotomy, major bleeding requiring blood transfusion, extensive adhesiolysis, injury to mediastinal structures, airway injury, nerve injury (phrenic, recurrent)
* Need for epidural or patient-controlled intravenous analgesia
* Need for urinary catheter
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jonathan Spicer

Assistant Professor of Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jonathan Spicer, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

McGill University Health Centre/Research Institute of the McGill University Health Centre

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

McGill University Health Centre

Montreal, Quebec, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jonathan Spicer, MD, PhD

Role: CONTACT

514-934-1934 ext. 43050

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jonathan Spicer, MD PhD

Role: primary

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-7318

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

National Emphysema Treatment Trial (NETT)
NCT00000606 COMPLETED PHASE3